News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
New Approaches to CAR-T Therapy
The FDA first approved of chimeric antigen receptor (CAR) T cell therapy in 2017, and Penn Medicine has since been dedicated to finding further applications to the treatment.
Penn Dental Medicine and Penn Engineering Faculty Invent Nanorobotic system That Offers new options for targeting fungal infections
This research team has developed a new way to accurately target and quickly destroy fungal cells in the mouth by using nanorobots guided by magnets.
Penn Dental Medicine Researchers Develop Plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin
Henry Daniell and his team of researchers developed a new plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin.
PCI Participates in Cellicon Valley ’23: The Future of Cell and Gene Therapies
Three staff members spoke at Track 5: “$tuff You Should Know about Starting Up and Spinning Out a Cell and Gene Biotech.”
Former Penn Engineering Faculty Develop Tau Scientific Instruments
Fang-Yen and Fouad co-founded the startup company Tau Scientific Instruments and have licensed the Penn technology.
Philadelphia Life Sciences Jobs Being Filled More by Women Than Men, Study Finds
The number of jobs held by women in the Philadelphia region's life sciences industry is growing at a faster rate than jobs held by men, according to a new report featured in the Philadelphia Business
Future mRNA Vaccine Applications Highlighted
The New York Post recently published an article discussing future applications of mRNA, including vaccinations against tuberculosis, malaria, high cholesterol, HIV, and more.
Penn Startups Win Several PACT Enterprise Awards
viTToria Biotherapeutics and Exyn Technologies, both startups co-founded by Penn faculty, won recent awards from the Philadelphia Alliance for Capital and Technologies.
4D Molecular Therapeutics (4DMT) Acquires Rights to Penn Medicine Invented Technology from Aevitas Therapeutics
Penn spinout Aevitas Therapeutics recently executed an asset purchase agreement with California-based biotechnology company 4D Molecular Therapeutics (4DMT).
Adult Schizophrenia Drug Wins FDA Approval
Teva Pharmaceuticals and MedinCell recently received approval from the U.S. Food and Drug Administration (FDA) for UZEDY™ (risperidone).